OncoInfluencers to Follow on Social Media: Dr. Rachel Riechelmann

We are excited to highlight Dr. Rachel Riechelmann as a key figure in the oncology field.

Dr. Rachel Riechelmann is a prominent presence on X/Twitter and LinkedIn, where she shares her extensive expertise in oncology, particularly in gastrointestinal tumors. She currently serves as the Director of the Clinical Oncology Department and Professor at AC Camargo Cancer Center in São Paulo, Brazil. Additionally, she is the President of the Brazilian GI Tumors Group (GTG), where she plays a crucial role in advancing research and treatment strategies for gastrointestinal cancers.

Her influential roles extend beyond her position at AC Camargo Cancer Center. Dr. Riechelmann is a valued member of several prestigious organizations, including the European Society for Medical Oncology (ESMO) Scientific Committees for Colorectal and Neuroendocrine Tumors (NET). She also contributes to the Latin American Society of GI Oncology (SLAGO), the European Society of Neuroendocrine Tumors Advisory Board, and serves as Chair of the GI Latin American Cooperative Oncology Group (LACOG).

Follow Dr. Rachel Riechelmann on X/Twitter and LinkedIn to stay informed about her pioneering work in gastrointestinal oncology and her significant contributions to advancing research and clinical practice in the field.

About Dr. Rachel Riechelmann

Dr. Rachel Riechelmann is a leading oncologist renowned for her expertise in gastrointestinal tumors. As the Director of the Clinical Oncology Department and Professor at AC Camargo Cancer Center in São Paulo, Brazil, she plays a pivotal role in the treatment and research of gastrointestinal cancers.

In her role as President of the Brazilian GI Tumors Group (GTG), Dr. Riechelmann leads efforts to advance research and improve patient care in this crucial area of oncology. Her involvement with the European Society for Medical Oncology (ESMO) Scientific Committees for Colorectal and Neuroendocrine Tumors, the Latin American Society of GI Oncology (SLAGO), and the European Society of Neuroendocrine Tumors Advisory Board underscores her influential position in the global oncology community.

Additionally, as Chair of the GI Latin American Cooperative Oncology Group (LACOG), she plays a key role in fostering collaboration and advancing clinical research across Latin America.

Dr. Rachel Riechelmann’s extensive experience and leadership continue to drive significant progress in gastrointestinal oncology.

Stay tuned for more OncoInfluencers and check out previous profiles on our website to discover other influential voices in the oncology community.